In cross-tumor studies, six immune subtypes including C1 (wound healing), C2 (INF-r-dominant), C3 (inflammation), C4 (lymphocyte depletion), C5 (immunologically silent), and C6 (TGF-β-dominant) were identified [15]. The gene discussed is TGFB1; the disease is neoplasm.